Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Labiotech.eu" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Labiotech.eu for you to read. Along with our medical data and news we also list Labiotech.eu Clinical Trials, which are updated daily. BioPortfolio also has a large database of Labiotech.eu Companies for you to search.
Idorsia will start a Phase III trial to study the efficacy of its drug in treating the constriction of arteries in the brain caused by release of chemicals linked to a previous bleed in this area. The Swiss biotech Idorsia ... The post Swiss Biotech Tackles Brain Artery Constriction Caused by Hemorrhage appeared first on Labiotech.eu.
Diabetes has become an epidemic, with over 422 million people affected worldwide sentenced to lifelong medication. Science is striving to find a cure to this chronic disease, but how close are we? Diabetes is the major cause of blindness, kidney ... The post The Future of Diabetes Treatment: Is a Cure Possible? appeared first on Labiotech.eu.
Finding the best therapy match for a tumor is a challenge—not only because there are so many treatment options to choose from, but also because of the high complexity of tumor biology. Sequencing technologies, especially state-of-the-art next generation sequencing (NGS) ... The post Finding The Best Match: RNA Sequencing for Cancer Therapy Decisions appeared first on Labiotech.eu.
ViiV Healthcare obtained positive Phase III results for its two-drug HIV treatment regimen, which could reduce toxicity as compared to the standard three-drug HIV treatments normally given to patients. ViiV Healthcare, a British biotech, has positive results from two Phase ... The post London Biotech Rakes in Positive Results for Two HIV Phase III Trials appeared first on Labiotech.eu.
Today, we’re in Ashdod, Israel, visiting Aleph Farms, a biotech that’s making cultured meat grown in a 3D environment that resembles the texture of natural meat. Mission: Founded in 2017, Aleph Farms uses cell samples taken from living cattle to ... The post This Israeli Biotech is Making Cultured Meat More Like the Real Thing appeared first on Labiotech.eu.
Mologic and Newcastle University have launched a diagnostic device that provides rapid information on herbicide resistance for a common weed, which could help cut major losses for the British agricultural industry. The partnership between academia and industry has developed a ... The post Device Helps Protect Cereals by Diagnosing Herbicide Resistance in Weeds appeared first on Labiotech.eu.
Do you like working with awesome people while working on stuff that’s actually interesting? Well hold on to your hats, we have some spots open in the coolest startup that ever was (not an exaggeration). Do you want to be ... The post Are You Intern-rested In Joining Our Marketing & Editorial Team? appeared first on Labiotech.eu.
Spanish researchers have developed a way to diagnose neurodegenerative diseases by analyzing eye movements. The Madrid-based research team and its spin-off company Aura Innovative Robotics have developed a diagnostic test for neurodegenerative disease that tracks a patient’s eye movements and ... The post Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease appe...
Cellectis is developing a new type of chimeric antigen receptor that could improve the production and safety of CAR-T cell therapies generated from both patient and donor cells. Cellectis, a French biotech focused on developing CAR-T therapies from donor cells, ... The post French Biotech Develops a New Generation of Safer CAR-T Cells appeared first on Labiotech.eu.
The Israeli biotech Pluristem has Phase II data indicating that its cell therapy made of placenta cells can help patients suffering from peripheral artery disease recover their mobility. The trial, run in the US, Germany, South Korea and Israel, enrolled ... The post Placenta Cell Therapy Improves Mobility in Patients with Peripheral Artery Disease appeared first on Labiotech.eu.
CAR-T cell therapy has been able to effectively treat cancer in some patients for whom all other treatment options were exhausted. However, the technology still has a long road ahead before becoming a widespread treatment option. Philip spoke to Christian ... The post CAR-T Brings Hope for Cancer Patients, But Challenges Lie Ahead appeared first on Labiotech.eu.
Biologics—antibodies, antigens, peptides, and other proteins—are frequently used as vaccines, but also for treatment of conditions such as cancer or diabetes. Biologics are typically produced in expression systems like yeast, E.coli, or mammalian cells. Even with elaborate purification protocols, traces ... The post Revealing the Identity of Host Cell Proteins for Better Drug Development appea...
Hello biotechnologists, Love biotech? Grab a spoon and dive into the industry with a job! Check out the position as a fermentation scientist at DNA Script or become the brand manager at Pfizer. Just starting out? Check out the internship in seed ... The post Grab A Biotech Spoon With A New Job! appeared first on Labiotech.eu.
Swiss and German scientists have engineered spider-silk microparticles that can be used to protect a vaccine particle, allow it to enter immune cells and trigger T-cell immunity without toxic effects. The team, partnered by AMSilk — the German biotech behind ... The post Spider Silk Shows Promise in Vaccine Field appeared first on Labiotech.eu.
Today is the First International NASH Day, and to mark the occasion, we bring you an update on Europe’s efforts to tackle this largely unrecognized liver disease that currently has no treatment and affects almost 12% of the adult population ... The post The European Fight Against NASH, The Silent Liver Disease appeared first on Labiotech.eu.
A study at Karolinska Institutet in Sweden has revealed that CRISPR-Cas9 gene editing could favor mutations in the most common cancer-causing gene. What does it mean for the first CRISPR therapy trials in humans? CRISPR-Cas9 has taken the life sciences ... The post Scientists Warn CRISPR Therapy Could Cause Cancer as First Human Trials Take Place appeared first on Labiotech.eu.
Saniona, a biotech focused on ion channel research, plans to test its lead candidate in a Phase IIa study for the rare eating disorder hypothalamic obesity. Saniona, based in Copenhagen, plans to start a Phase IIa trial testing its product, ... The post Danish Biotech Plans Phase II Study to Fight A Rare Eating Disorder appeared first on Labiotech.eu.
The capital of one of the happiest countries in the world, Copenhagen has become a big hub for biotech in Europe. Here are some of the best biotech companies brewing in the Danish capital. Following the example of Novo Nordisk, ... The post The Top 10 Biotech Companies in Copenhagen appeared first on Labiotech.eu.
RSP Systems has raised €6.5M in the first closing of a Series B round to fund clinical trials for its needle-free blood sugar monitoring device for diabetes. RSP Systems, a Danish non-invasive diagnostics company, has completed the first of two ... The post Non Invasive Glucose Monitoring Device Moves Forward With Series B Funding appeared first on Labiotech.eu.
It is not often that we come across a topic that is so fundamentally important to humankind, yet so rarely discussed: pediatric drug development. Did you know that merely a decade ago, the majority of medications given to children had ... The post Riding the Wave of Pediatric Drug Development appeared first on Labiotech.eu.
In the process of studying HIV-infected patients who naturally don’t need therapy to control the virus, scientists have found what could become a functional cure for HIV infections. A team of researchers from France, Italy, the UK and Australia have ... The post People with Innate Resistance to HIV Could Provide a Functional HIV Cure appeared first on Labiotech.eu.
German researchers are exploring ways of using chitosan, which is derived from a component of insect skin called chitin, to replace toxic chemicals in the production of textiles. The researchers, who are based at the Fraunhofer Institute for Interfacial Engineering ... The post The Textile Industry May Soon Turn to Insects to Help Produce Fabrics appeared first on Labiotech.eu.
This week we’re in Ness Ziona, Israel, visiting CollPlant, a biotech that engineers tobacco plants to produce collagen for a variety of uses, including 3D printing and artificial tendons. Mission: CollPlant engineers tobacco plants to express five human genes, which ... The post This Israeli Biotech Engineers Tobacco Plants to Make Collagen appeared first on Labiotech.eu.
UK biotech Microbiotica has entered into a multi-year collaboration with Genentech, one of the world’s first biotechs, to develop microbiome-based treatments for inflammatory bowel disease. Microbiotica, based in Cambridge, UK has entered into a collaboration with Genentech that could be ... The post Microbiome Company Enters $534M Deal With Genentech To Develop Treatments for IBD appeared first...
Our team has been at the center of the digital transformation of the Life Science industry. After only a few years of existence, we grew Labiotech.eu to be the leading digital media for Biotech in Europe. To keep our website free, we also ... The post Discover Labiotech Reach, The Blog for Curious Life Science Marketers appeared first on Labiotech.eu.